The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Primary Hepatocytes-Global Market Insights and Sales Trends 2024

Primary Hepatocytes-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1870305

No of Pages : 121

Ask Your Query
Synopsis
The global Primary Hepatocytes market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Primary Hepatocytes in various end use industries. The expanding demands from the Life Science Research Companies, Research Institutes and Others,, are propelling Primary Hepatocytes market. Human Primary Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Primary Cells segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Primary Hepatocytes market, driven by demand from China, the second largest economy with some signs of stabilising, the Primary Hepatocytes market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Primary Hepatocytes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Primary Hepatocytes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Primary Hepatocytes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Primary Hepatocytes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Primary Hepatocytes covered in this report include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc.
The global Primary Hepatocytes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza
Cell Biologics, Inc.
PromoCell GmbH
HemaCare Corporation
ZenBio, Inc.
STEMCELL Technologies, Inc.
Corning Incorporated
AllCells
Axol Bioscience Ltd.
iXCells Biotechnologies
Neuromics
StemExpress
BioIVT
ScienCell Research Laboratories, Inc.
PPA Research Group, Inc.
Creative Bioarray
BPS Bioscience, Inc.
Epithelix Sàrl
ReachBio LLC
AcceGen
Sekisui XenoTech, LLC
Biopredic International
Global Primary Hepatocytes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Primary Hepatocytes market, Segment by Type:
Human Primary Cells
Animal Primary Cells
Global Primary Hepatocytes market, by Application
Life Science Research Companies
Research Institutes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Primary Hepatocytes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Primary Hepatocytes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Primary Hepatocytes Market Overview
1.1 Primary Hepatocytes Product Overview
1.2 Primary Hepatocytes Market Segment by Type
1.2.1 Human Primary Cells
1.2.2 Animal Primary Cells
1.3 Global Primary Hepatocytes Market Size by Type
1.3.1 Global Primary Hepatocytes Market Size Overview by Type (2018-2029)
1.3.2 Global Primary Hepatocytes Historic Market Size Review by Type (2018-2023)
1.3.3 Global Primary Hepatocytes Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.2 Europe Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Primary Hepatocytes Sales Breakdown by Type (2018-2023)
2 Global Primary Hepatocytes Market Competition by Company
2.1 Global Top Players by Primary Hepatocytes Sales (2018-2023)
2.2 Global Top Players by Primary Hepatocytes Revenue (2018-2023)
2.3 Global Top Players by Primary Hepatocytes Price (2018-2023)
2.4 Global Top Manufacturers Primary Hepatocytes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Primary Hepatocytes Market Competitive Situation and Trends
2.5.1 Primary Hepatocytes Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Primary Hepatocytes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primary Hepatocytes as of 2022)
2.7 Date of Key Manufacturers Enter into Primary Hepatocytes Market
2.8 Key Manufacturers Primary Hepatocytes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Primary Hepatocytes Status and Outlook by Region
3.1 Global Primary Hepatocytes Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Primary Hepatocytes Historic Market Size by Region
3.2.1 Global Primary Hepatocytes Sales in Volume by Region (2018-2023)
3.2.2 Global Primary Hepatocytes Sales in Value by Region (2018-2023)
3.2.3 Global Primary Hepatocytes Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Primary Hepatocytes Forecasted Market Size by Region
3.3.1 Global Primary Hepatocytes Sales in Volume by Region (2024-2029)
3.3.2 Global Primary Hepatocytes Sales in Value by Region (2024-2029)
3.3.3 Global Primary Hepatocytes Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Primary Hepatocytes by Application
4.1 Primary Hepatocytes Market Segment by Application
4.1.1 Life Science Research Companies
4.1.2 Research Institutes
4.1.3 Others
4.2 Global Primary Hepatocytes Market Size by Application
4.2.1 Global Primary Hepatocytes Market Size Overview by Application (2018-2029)
4.2.2 Global Primary Hepatocytes Historic Market Size Review by Application (2018-2023)
4.2.3 Global Primary Hepatocytes Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.2 Europe Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Primary Hepatocytes Sales Breakdown by Application (2018-2023)
5 North America Primary Hepatocytes by Country
5.1 North America Primary Hepatocytes Historic Market Size by Country
5.1.1 North America Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Primary Hepatocytes Sales in Volume by Country (2018-2023)
5.1.3 North America Primary Hepatocytes Sales in Value by Country (2018-2023)
5.2 North America Primary Hepatocytes Forecasted Market Size by Country
5.2.1 North America Primary Hepatocytes Sales in Volume by Country (2024-2029)
5.2.2 North America Primary Hepatocytes Sales in Value by Country (2024-2029)
6 Europe Primary Hepatocytes by Country
6.1 Europe Primary Hepatocytes Historic Market Size by Country
6.1.1 Europe Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Primary Hepatocytes Sales in Volume by Country (2018-2023)
6.1.3 Europe Primary Hepatocytes Sales in Value by Country (2018-2023)
6.2 Europe Primary Hepatocytes Forecasted Market Size by Country
6.2.1 Europe Primary Hepatocytes Sales in Volume by Country (2024-2029)
6.2.2 Europe Primary Hepatocytes Sales in Value by Country (2024-2029)
7 Asia-Pacific Primary Hepatocytes by Region
7.1 Asia-Pacific Primary Hepatocytes Historic Market Size by Region
7.1.1 Asia-Pacific Primary Hepatocytes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Primary Hepatocytes Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Primary Hepatocytes Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Primary Hepatocytes Forecasted Market Size by Region
7.2.1 Asia-Pacific Primary Hepatocytes Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Primary Hepatocytes Sales in Value by Region (2024-2029)
8 Latin America Primary Hepatocytes by Country
8.1 Latin America Primary Hepatocytes Historic Market Size by Country
8.1.1 Latin America Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Primary Hepatocytes Sales in Volume by Country (2018-2023)
8.1.3 Latin America Primary Hepatocytes Sales in Value by Country (2018-2023)
8.2 Latin America Primary Hepatocytes Forecasted Market Size by Country
8.2.1 Latin America Primary Hepatocytes Sales in Volume by Country (2024-2029)
8.2.2 Latin America Primary Hepatocytes Sales in Value by Country (2024-2029)
9 Middle East and Africa Primary Hepatocytes by Country
9.1 Middle East and Africa Primary Hepatocytes Historic Market Size by Country
9.1.1 Middle East and Africa Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Primary Hepatocytes Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Primary Hepatocytes Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Primary Hepatocytes Forecasted Market Size by Country
9.2.1 Middle East and Africa Primary Hepatocytes Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Primary Hepatocytes Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Thermo Fisher Scientific, Inc. Company Information
10.1.2 Thermo Fisher Scientific, Inc. Introduction and Business Overview
10.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Thermo Fisher Scientific, Inc. Primary Hepatocytes Products Offered
10.1.5 Thermo Fisher Scientific, Inc. Recent Development
10.2 Merck KGaA
10.2.1 Merck KGaA Company Information
10.2.2 Merck KGaA Introduction and Business Overview
10.2.3 Merck KGaA Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck KGaA Primary Hepatocytes Products Offered
10.2.5 Merck KGaA Recent Development
10.3 Lonza
10.3.1 Lonza Company Information
10.3.2 Lonza Introduction and Business Overview
10.3.3 Lonza Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lonza Primary Hepatocytes Products Offered
10.3.5 Lonza Recent Development
10.4 Cell Biologics, Inc.
10.4.1 Cell Biologics, Inc. Company Information
10.4.2 Cell Biologics, Inc. Introduction and Business Overview
10.4.3 Cell Biologics, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cell Biologics, Inc. Primary Hepatocytes Products Offered
10.4.5 Cell Biologics, Inc. Recent Development
10.5 PromoCell GmbH
10.5.1 PromoCell GmbH Company Information
10.5.2 PromoCell GmbH Introduction and Business Overview
10.5.3 PromoCell GmbH Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 PromoCell GmbH Primary Hepatocytes Products Offered
10.5.5 PromoCell GmbH Recent Development
10.6 HemaCare Corporation
10.6.1 HemaCare Corporation Company Information
10.6.2 HemaCare Corporation Introduction and Business Overview
10.6.3 HemaCare Corporation Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 HemaCare Corporation Primary Hepatocytes Products Offered
10.6.5 HemaCare Corporation Recent Development
10.7 ZenBio, Inc.
10.7.1 ZenBio, Inc. Company Information
10.7.2 ZenBio, Inc. Introduction and Business Overview
10.7.3 ZenBio, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ZenBio, Inc. Primary Hepatocytes Products Offered
10.7.5 ZenBio, Inc. Recent Development
10.8 STEMCELL Technologies, Inc.
10.8.1 STEMCELL Technologies, Inc. Company Information
10.8.2 STEMCELL Technologies, Inc. Introduction and Business Overview
10.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.8.4 STEMCELL Technologies, Inc. Primary Hepatocytes Products Offered
10.8.5 STEMCELL Technologies, Inc. Recent Development
10.9 Corning Incorporated
10.9.1 Corning Incorporated Company Information
10.9.2 Corning Incorporated Introduction and Business Overview
10.9.3 Corning Incorporated Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Corning Incorporated Primary Hepatocytes Products Offered
10.9.5 Corning Incorporated Recent Development
10.10 AllCells
10.10.1 AllCells Company Information
10.10.2 AllCells Introduction and Business Overview
10.10.3 AllCells Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.10.4 AllCells Primary Hepatocytes Products Offered
10.10.5 AllCells Recent Development
10.11 Axol Bioscience Ltd.
10.11.1 Axol Bioscience Ltd. Company Information
10.11.2 Axol Bioscience Ltd. Introduction and Business Overview
10.11.3 Axol Bioscience Ltd. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Axol Bioscience Ltd. Primary Hepatocytes Products Offered
10.11.5 Axol Bioscience Ltd. Recent Development
10.12 iXCells Biotechnologies
10.12.1 iXCells Biotechnologies Company Information
10.12.2 iXCells Biotechnologies Introduction and Business Overview
10.12.3 iXCells Biotechnologies Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.12.4 iXCells Biotechnologies Primary Hepatocytes Products Offered
10.12.5 iXCells Biotechnologies Recent Development
10.13 Neuromics
10.13.1 Neuromics Company Information
10.13.2 Neuromics Introduction and Business Overview
10.13.3 Neuromics Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Neuromics Primary Hepatocytes Products Offered
10.13.5 Neuromics Recent Development
10.14 StemExpress
10.14.1 StemExpress Company Information
10.14.2 StemExpress Introduction and Business Overview
10.14.3 StemExpress Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.14.4 StemExpress Primary Hepatocytes Products Offered
10.14.5 StemExpress Recent Development
10.15 BioIVT
10.15.1 BioIVT Company Information
10.15.2 BioIVT Introduction and Business Overview
10.15.3 BioIVT Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.15.4 BioIVT Primary Hepatocytes Products Offered
10.15.5 BioIVT Recent Development
10.16 ScienCell Research Laboratories, Inc.
10.16.1 ScienCell Research Laboratories, Inc. Company Information
10.16.2 ScienCell Research Laboratories, Inc. Introduction and Business Overview
10.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.16.4 ScienCell Research Laboratories, Inc. Primary Hepatocytes Products Offered
10.16.5 ScienCell Research Laboratories, Inc. Recent Development
10.17 PPA Research Group, Inc.
10.17.1 PPA Research Group, Inc. Company Information
10.17.2 PPA Research Group, Inc. Introduction and Business Overview
10.17.3 PPA Research Group, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.17.4 PPA Research Group, Inc. Primary Hepatocytes Products Offered
10.17.5 PPA Research Group, Inc. Recent Development
10.18 Creative Bioarray
10.18.1 Creative Bioarray Company Information
10.18.2 Creative Bioarray Introduction and Business Overview
10.18.3 Creative Bioarray Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Creative Bioarray Primary Hepatocytes Products Offered
10.18.5 Creative Bioarray Recent Development
10.19 BPS Bioscience, Inc.
10.19.1 BPS Bioscience, Inc. Company Information
10.19.2 BPS Bioscience, Inc. Introduction and Business Overview
10.19.3 BPS Bioscience, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.19.4 BPS Bioscience, Inc. Primary Hepatocytes Products Offered
10.19.5 BPS Bioscience, Inc. Recent Development
10.20 Epithelix Sàrl
10.20.1 Epithelix Sàrl Company Information
10.20.2 Epithelix Sàrl Introduction and Business Overview
10.20.3 Epithelix Sàrl Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Epithelix Sàrl Primary Hepatocytes Products Offered
10.20.5 Epithelix Sàrl Recent Development
10.21 ReachBio LLC
10.21.1 ReachBio LLC Company Information
10.21.2 ReachBio LLC Introduction and Business Overview
10.21.3 ReachBio LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.21.4 ReachBio LLC Primary Hepatocytes Products Offered
10.21.5 ReachBio LLC Recent Development
10.22 AcceGen
10.22.1 AcceGen Company Information
10.22.2 AcceGen Introduction and Business Overview
10.22.3 AcceGen Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.22.4 AcceGen Primary Hepatocytes Products Offered
10.22.5 AcceGen Recent Development
10.23 Sekisui XenoTech, LLC
10.23.1 Sekisui XenoTech, LLC Company Information
10.23.2 Sekisui XenoTech, LLC Introduction and Business Overview
10.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Sekisui XenoTech, LLC Primary Hepatocytes Products Offered
10.23.5 Sekisui XenoTech, LLC Recent Development
10.24 Biopredic International
10.24.1 Biopredic International Company Information
10.24.2 Biopredic International Introduction and Business Overview
10.24.3 Biopredic International Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Biopredic International Primary Hepatocytes Products Offered
10.24.5 Biopredic International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Primary Hepatocytes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Primary Hepatocytes Industrial Chain Analysis
11.4 Primary Hepatocytes Market Dynamics
11.4.1 Primary Hepatocytes Industry Trends
11.4.2 Primary Hepatocytes Market Drivers
11.4.3 Primary Hepatocytes Market Challenges
11.4.4 Primary Hepatocytes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Primary Hepatocytes Distributors
12.3 Primary Hepatocytes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock